Heren Health Co., Ltd. Class A

Heren Health Co., Ltd. Class A

SSZSE:300550
13.95
CNY
+0.64
(+4.81%)
-0.10EPS
3.63BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.02
1.37
1.36
1.35
1.25
1.78
1.99
1.9
1.75
1.38
1.68
1.55
1.64
1.48
Basic EPS, GAAP
0.32
0.28
0.31
0.3
0.15
0.18
0.19
0.18
0.13
-0.32
0.15
0.15
0.18
-0.11
Free Cash Flow per Basic Share
0.02
-0.19
0.03
-0.17
0.03
- -
0.11
-0.55
-0.36
-0.49
0.22
-0.14
0.32
- -
Dividend per Share
- -
- -
0.02
0.02
0.04
0.03
0.05
0.04
0.03
0.03
0.02
0.05
0.03
0.04
Book Value per Share
0.71
0.99
1.3
2.19
2.3
2.4
2.35
4.12
4.27
3.96
4.11
4.23
4.39
4.12
Tangible Book Value per Share
0.67
0.95
1.27
2.14
2.25
2.34
2.3
3.97
4.03
3.7
3.84
3.96
4.04
3.76
Basic Weighted Avg Shares
137
165
165
174
220
220
222
240
265
260
261
262
265
263
Sales/Revenue/Turnover
140
227
225
236
276
391
441
455
464
360
439
406
435
388
Operating Margin (%)
22.92
19.37
18.42
21.29
16.92
16.87
15.85
17.14
8.94
-15.8
10.71
18.58
19.38
-1.04
Depreciation Expense
1
2
2
3
12
12
13
13
19
30
33
35
29
- -
Net Income, GAAP
44
46
52
52
33
40
41
43
34
-83
39
39
48
-28
Effective Tax Rate (%)
- -
11.02
11.03
11.03
11.38
10.57
6.12
11.75
1.86
- -
5
0.34
4.24
- -
Profit Margin (%)
31.42
20.44
22.98
22.1
11.91
10.33
9.35
9.49
7.43
-23.12
8.91
9.68
10.96
-7.23
Working Capital
111
121
128
311
301
349
343
871
897
771
832
859
881
810
LT Debt
9
31
41
- -
- -
- -
- -
1
1
1
1
- -
1
2
Total Equity
116
162
217
486
515
558
551
1,125
1,161
1,042
1,080
1,120
1,178
1,108
Return on Invested Capital (%)
- -
21.72
15.06
9.64
6.68
6.74
7.08
4.87
2.97
- -
3.72
3.45
4.73
- -
Return on Capital (%)
- -
29.58
22.14
13.67
6.41
7.44
7.09
4.94
2.98
- -
3.62
3.76
4.05
- -
Return on Common Equity (%)
55.5
33.32
27.47
15.01
6.68
7.69
7.58
5.28
3.1
-7.67
3.69
3.59
4.21
-2.57

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1
2
1
LT Borrowings
- -
- -
- -
LT Finance Leases
1
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
263
263
263
Market Capitalization
3,156
3,500
3,634

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,129
1,110
1,086
Cash, Cash Equivalents & STI
476
448
429
Accounts Receivable, Net
277
261
270
Inventories
36
46
58
Total Current Liabilities
252
268
276
Payables & Accruals
- -
- -
- -
ST Debt
1
2
1
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.63%
1.11%
5.25%
Free Cash Flow
37.8%
-125.29%
-321.16%
Net Income, GAAP
-49.35%
-97.38%
21.29%
Sales/Revenue/Turnover
8.06%
0.24%
7.15%
Total Cash Common Dividend
28.54%
16.54%
-26.91%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
91
69
104
142
406
2025
78
80
- -
172
435
2026
76
82
59
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.05
0.06
0.15
0.15
2025
-0.01
- -
- -
0.13
0.18
2026
-0.03
-0.09
-0.12
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.03
- -
- -
0.05
2025
- -
0.03
- -
- -
0.03
2026
- -
0.03
- -
- -
- -

Company Description

CEO
Chen Hui Zhao
Full Time Employees
794
Sector
Technology services
Industry
Packaged software
Address
Hangzhou China
IPO Date
Oct 18, 2016
Business
Heren Health Co., Ltd. is a China-based healthcare information technology provider that specializes in the research, development, system integration, software implementation, and technical maintenance of smart healthcare informatics and regional digital health infrastructure. Founded in 2010 and headquartered in Hangzhou, Zhejiang Province, the company delivers digital solutions to top-tier tertiary hospitals, multi-campus healthcare groups, specialized medical consortiums, and municipal health administrations throughout the People's Republic of China. The company operates through core business segments focused on hospital clinical information systems, scenario-based digital healthcare applications, and urban smart health cloud platforms. Heren Health provides an extensive portfolio of proprietary products and services, which includes next-generation cloud-native Hospital Information Systems (HIS) unifying administrative and clinical workflows; high-level Electronic Medical Record (EMR) systems; enterprise Hospital Integration Platforms and Clinical Data Repositories (CDR/CDR+) for cross-departmental data standardization and interoperability across Laboratory Information Systems (LIS), Picture Archiving and Communication Systems (PACS), and Radiology Information Systems (RIS); the MindHub Artificial Intelligence Middle Office platform enabling clinical decision support systems (CDSS), automated TNM cancer staging, and intelligent diagnostic triage; the Hospital Control Center (HCC) integrated operational management suite; the Hi-Doctor series of mobile clinician and nursing workstations; specialized clinical scenario applications for smart outpatient management, digital inpatient wards, smart operating rooms, and smart intensive care units (ICUs); internet hospital platforms facilitating remote consultations and telehealth services; and regional healthcare platforms designed for medical consortium resource allocation and Smart Health City administrative coordination. In recent corporate developments, Heren Health has executed strategic equity transactions and commercial alliances to enhance its market position, including bringing Topchoice Medical Corporation on board as a major strategic shareholder and establishing the joint venture Zhejiang Meihesuo Information Technology Co., Ltd. (51% held by Heren Health and 49% by Topchoice Medical) to deliver specialized digital clinical cloud software. Furthermore, the company has advanced the integration of medical large language models and generative artificial intelligence into its MindHub platform, deepened strategic cloud collaborations with technology partners such as Tencent Cloud, and accelerated the deployment of localized Information Technology Application Innovation (Xinchuang)-compliant healthcare software architectures across leading public hospital networks in China.